Found: 2
Select item for more details and to access through your institution.
Corrigendum: IRAK1 is a therapeutic target that drives breast cancer metastasis and resistance to paclitaxel.
- Published in:
- Nature Communications, 2015, v. 6, n. 11, p. 10054, doi. 10.1038/ncomms10054
- By:
- Publication type:
- Article
IRAK1 is a therapeutic target that drives breast cancer metastasis and resistance to paclitaxel.
- Published in:
- Nature Communications, 2015, v. 6, n. 10, p. 8746, doi. 10.1038/ncomms9746
- By:
- Publication type:
- Article